Brief: Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings From Pivotal Clinical Trial Of Oxylanthanum Carbonate (OLC)
10/07/2024 12:15
July 10 (Reuters) - Unicycive Therapeutics Inc UNCY.O :
* UNICYCIVE THERAPEUTICS ANNOUNCES INITIAL POSITIVE PATIENT
SATISFACTION FINDINGS FROM PIVOTAL CLINICAL TRIAL OF
OXYLANTHANUM CARBONATE (OLC)
* UNICYCIVE THERAPEUTICS INC - MEDIAN DAILY PILL BURDEN
REDUCED BY
HALF AFTER SWITCH TO OLC
* UNICYCIVE THERAPEUTICS INC - PATIENTS PREFER OLC MORE THAN
4 TO
1 OVER PRIOR PHOSPHATE BINDER THERAPY
Source text for Eikon: ID:nGNXbLVht9
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss